Statement by the Minister of Health, Dr Zwelini Mkhize, on the FDA’s Temporary Suspension of Johnson and Johnson vaccine rollout in the United States.
13 April 2021
We have noted the decision taken by the Food and Drug Administration in the United States of America to advise the temporary suspension of the Johnson and Johnson vaccine rollout in the US.
This has occurred to due reports of 6 females who developed unusual blood clots with low platelets. These incidents occurred between 6 and 13 days after vaccination in women between the ages of 18 and 48 years old. It must be noted that over over 6,6 million citizens have been inoculated with Johnson and Johnson vaccine in the U.S.
In South Africa, we have not had any reports of clots that have formed after vaccination, and this is after having inoculated 289 787 health care workers under the Sisonke Protocol.
Having said that, after this advisory came to my attention I held urgent consultations with our scientists, who have advised that we cannot take the decision made by the FDA lightly. Based on their advise, we have determined to voluntarily suspend our rollout until the causal relationship between the development of clots and the Johnson and Johnson vaccine is sufficiently interrogated.